Literature DB >> 22747676

Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants.

M Camilleri1, J Iturrino, A E Bharucha, D Burton, A Shin, I-D Jeong, A R Zinsmeister.   

Abstract

BACKGROUND: Gastric emptying (GE) is measured in pharmacodynamic and diagnostic studies. Our aim was to assess inter- and intra-subject coefficients of variation (COV) of scintigraphic GE measurements in healthy subjects, and associations of GE with gender and body mass index (BMI).
METHODS: Data from participants with scintigraphic measurements of gastric emptying of solids were analyzed. Primary endpoints were gastric emptying T(1/2) (GE T(1/2) ) and GE at 1, 2, 3, and 4 h. KEY
RESULTS: The patient cohort consisted of 105 males and 214 females; at least two studies were performed in 47 subjects [16 males (M), 32 females (F)]. Inter-subject COV (COV(inter) ) for GE T(1/2) were similar in M and F: overall 24.5% (M 26.0%, F 22.5%); COV are predictably lowest for GE at 4 h (COV(inter) 9.6%). COV(intra) for T(1/2) and GE at 4 h were overall 23.8% and 12.6%, and were similar to COV(inter) values. Gender (but not age or BMI) was significantly associated with GE T1/2 [P < 0.001, F 127.6 ± 28.7 (SD) min; M 109.9 ± 28.6 min] and with GE at 1 h and 2 h. Repeat GE T(1/2) values in 47 participants were significantly correlated (r = 0.459, P < 0.001) with median difference of -6 min (mean -1.6, range -56 to 72 min). Bland-Altman plots showed Δ GE T(1/2) similarly distributed across mean GE T(1/2) 100-155 min, and across studies conducted 90-600 days apart. CONCLUSIONS & INFERENCES: Inter-subject variations in scintigraphic GE results are only slightly higher than the intra-subject measurements, which are also reproducible over time in healthy volunteers. Gender, but not BMI, is significantly associated with GE results.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22747676      PMCID: PMC3465511          DOI: 10.1111/j.1365-2982.2012.01972.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  20 in total

1.  Assessment of functional gastrointestinal disease: the bowel disease questionnaire.

Authors:  N J Talley; S F Phillips; C M Wiltgen; A R Zinsmeister; L J Melton
Journal:  Mayo Clin Proc       Date:  1990-11       Impact factor: 7.616

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus.

Authors:  Karen L Jones; Antonietta Russo; Melanie K Berry; Julie E Stevens; Judith M Wishart; Michael Horowitz
Journal:  Am J Med       Date:  2002-10-15       Impact factor: 4.965

4.  Assessment of gastric emptying using a low fat meal: establishment of international control values.

Authors:  G Tougas; E Y Eaker; T L Abell; H Abrahamsson; M Boivin; J Chen; M P Hocking; E M Quigley; K L Koch; A Z Tokayer; V Stanghellini; Y Chen; J D Huizinga; J Rydén; I Bourgeois; R W McCallum
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

5.  Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity.

Authors:  Henry P Parkman; Katherine Yates; William L Hasler; Linda Nguyen; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Kenneth L Koch; Thomas L Abell; Richard W McCallum; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton
Journal:  Gastroenterology       Date:  2010-10-20       Impact factor: 22.682

6.  Performance characteristics of scintigraphic transit measurements for studies of experimental therapies.

Authors:  F Cremonini; B P Mullan; M Camilleri; D D Burton; M R Rank
Journal:  Aliment Pharmacol Ther       Date:  2002-10       Impact factor: 8.171

7.  Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.

Authors:  A Foxx-Orenstein; M Camilleri; D Stephens; D Burton
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

8.  Independent influences of body mass and gastric volumes on satiation in humans.

Authors:  Silvia Delgado-Aros; Filippo Cremonini; Janet E Castillo; Heather J Chial; Duane D Burton; Irene Ferber; Michael Camilleri
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

9.  Human gastric emptying and colonic filling of solids characterized by a new method.

Authors:  M Camilleri; L J Colemont; S F Phillips; M L Brown; G M Thomforde; N Chapman; A R Zinsmeister
Journal:  Am J Physiol       Date:  1989-08

10.  Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.

Authors:  M Camilleri; J R Malagelada; T L Abell; M L Brown; V Hench; A R Zinsmeister
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

View more
  54 in total

1.  Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health.

Authors:  Houssam Halawi; Michael Camilleri; Andres Acosta; Maria Vazquez-Roque; Ibironke Oduyebo; Duane Burton; Irene Busciglio; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

2.  Novel and validated approaches for gastric emptying scintigraphy in patients with suspected gastroparesis.

Authors:  Michael Camilleri; Andrea Shin
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

3.  Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders.

Authors:  G Parthasarathy; K Ravi; M Camilleri; C Andrews; L A Szarka; P A Low; A R Zinsmeister; A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2015-09-20       Impact factor: 3.598

Review 4.  Current management strategies and emerging treatments for functional dyspepsia.

Authors:  Michael Camilleri; Vincenzo Stanghellini
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-05       Impact factor: 46.802

5.  Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms.

Authors:  A Desai; M O'Connor; B Neja; K Delaney; M Camilleri; A R Zinsmeister; A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2018-05-02       Impact factor: 3.598

6.  Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Maria I Vazquez-Roque; Johanna Iturrino; Duane Burton; Jessica O'Neill; Deborah Eckert; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2014-12-06       Impact factor: 22.682

7.  Disturbances of gastrointestinal transit and autonomic functions in postural orthostatic tachycardia syndrome.

Authors:  A Loavenbruck; J Iturrino; W Singer; D M Sletten; P A Low; A R Zinsmeister; A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2014-12-06       Impact factor: 3.598

8.  Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.

Authors:  Johanna Iturrino; Michael Camilleri; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Dig Liver Dis       Date:  2013-10-04       Impact factor: 4.088

9.  GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 Antagonist.

Authors:  Subhankar Chakraborty; Magnus Halland; Duane Burton; Anshuman Desai; Bridget Neja; Phillip Low; Wolfgang Singer; Michael Camilleri; Alan R Zinsmeister; Adil E Bharucha
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

10.  Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight.

Authors:  Mark Topazian; Michael Camilleri; Felicity T Enders; Jonathan E Clain; Ferga C Gleeson; Michael J Levy; Elizabeth Rajan; Vandana Nehra; Ross A Dierkhising; Maria L Collazo-Clavell; Nicholas J Talley; Matthew M Clark
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-09       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.